For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy. This report contains market size and forecasts of Cancer Biopsy in global, including the following market information:
Global Cancer Biopsy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Biopsy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tissue Biopsies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biopsy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biopsy Market Segment Percentages, by Type, 2022 (%)
Tissue Biopsies
Liquid Biopsies
Others
Global Cancer Biopsy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biopsy Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Global Cancer Biopsy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Biopsy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biopsy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Biopsy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biopsy, market overview.
Chapter 2: Global Cancer Biopsy market size in revenue.
Chapter 3: Detailed analysis of Cancer Biopsy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biopsy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biopsy Overall Market Size
2.1 Global Cancer Biopsy Market Size: 2022 VS 2029
2.2 Global Cancer Biopsy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Biopsy Players in Global Market
3.2 Top Global Cancer Biopsy Companies Ranked by Revenue
3.3 Global Cancer Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biopsy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biopsy Market Size Markets, 2022 & 2029
4.1.2 Tissue Biopsies
4.1.3 Liquid Biopsies
4.1.4 Others
4.2 By Type - Global Cancer Biopsy Revenue & Forecasts
4.2.1 By Type - Global Cancer Biopsy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Biopsy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Biopsy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biopsy Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Colorectal Cancer
5.1.4 Cervical Cancers
5.1.5 Lung Cancers
5.1.6 Prostate Cancers
5.1.7 Skin Cancers
5.1.8 Blood Cancers
5.1.9 Kidney Cancers
5.1.10 Others
5.2 By Application - Global Cancer Biopsy Revenue & Forecasts
5.2.1 By Application - Global Cancer Biopsy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Biopsy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Biopsy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Biopsy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Biopsy Revenue & Forecasts
6.2.1 By Region - Global Cancer Biopsy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Biopsy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Biopsy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Biopsy Revenue, 2018-2029
6.3.2 US Cancer Biopsy Market Size, 2018-2029
6.3.3 Canada Cancer Biopsy Market Size, 2018-2029
6.3.4 Mexico Cancer Biopsy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Biopsy Revenue, 2018-2029
6.4.2 Germany Cancer Biopsy Market Size, 2018-2029
6.4.3 France Cancer Biopsy Market Size, 2018-2029
6.4.4 U.K. Cancer Biopsy Market Size, 2018-2029
6.4.5 Italy Cancer Biopsy Market Size, 2018-2029
6.4.6 Russia Cancer Biopsy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Biopsy Market Size, 2018-2029
6.4.8 Benelux Cancer Biopsy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Biopsy Revenue, 2018-2029
6.5.2 China Cancer Biopsy Market Size, 2018-2029
6.5.3 Japan Cancer Biopsy Market Size, 2018-2029
6.5.4 South Korea Cancer Biopsy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Biopsy Market Size, 2018-2029
6.5.6 India Cancer Biopsy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Biopsy Revenue, 2018-2029
6.6.2 Brazil Cancer Biopsy Market Size, 2018-2029
6.6.3 Argentina Cancer Biopsy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Biopsy Revenue, 2018-2029
6.7.2 Turkey Cancer Biopsy Market Size, 2018-2029
6.7.3 Israel Cancer Biopsy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Biopsy Market Size, 2018-2029
6.7.5 UAE Cancer Biopsy Market Size, 2018-2029
7 Cancer Biopsy Companies Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Company Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Biopsy Major Product Offerings
7.1.4 Qiagen N.V. Cancer Biopsy Revenue in Global Market (2018-2023)
7.1.5 Qiagen N.V. Key News & Latest Developments
7.2 Illumina, Inc.
7.2.1 Illumina, Inc. Company Summary
7.2.2 Illumina, Inc. Business Overview
7.2.3 Illumina, Inc. Cancer Biopsy Major Product Offerings
7.2.4 Illumina, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.2.5 Illumina, Inc. Key News & Latest Developments
7.3 ANGLE Plc
7.3.1 ANGLE Plc Company Summary
7.3.2 ANGLE Plc Business Overview
7.3.3 ANGLE Plc Cancer Biopsy Major Product Offerings
7.3.4 ANGLE Plc Cancer Biopsy Revenue in Global Market (2018-2023)
7.3.5 ANGLE Plc Key News & Latest Developments
7.4 Myriad Genetics
7.4.1 Myriad Genetics Company Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Cancer Biopsy Major Product Offerings
7.4.4 Myriad Genetics Cancer Biopsy Revenue in Global Market (2018-2023)
7.4.5 Myriad Genetics Key News & Latest Developments
7.5 Hologic, Inc.
7.5.1 Hologic, Inc. Company Summary
7.5.2 Hologic, Inc. Business Overview
7.5.3 Hologic, Inc. Cancer Biopsy Major Product Offerings
7.5.4 Hologic, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.5.5 Hologic, Inc. Key News & Latest Developments
7.6 Biocept, Inc.
7.6.1 Biocept, Inc. Company Summary
7.6.2 Biocept, Inc. Business Overview
7.6.3 Biocept, Inc. Cancer Biopsy Major Product Offerings
7.6.4 Biocept, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.6.5 Biocept, Inc. Key News & Latest Developments
7.7 Thermo Fisher Scientific, Inc.
7.7.1 Thermo Fisher Scientific, Inc. Company Summary
7.7.2 Thermo Fisher Scientific, Inc. Business Overview
7.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Major Product Offerings
7.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.7.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.8 Danaher
7.8.1 Danaher Company Summary
7.8.2 Danaher Business Overview
7.8.3 Danaher Cancer Biopsy Major Product Offerings
7.8.4 Danaher Cancer Biopsy Revenue in Global Market (2018-2023)
7.8.5 Danaher Key News & Latest Developments
7.9 Lucence Diagnostics Pte. Ltd.
7.9.1 Lucence Diagnostics Pte. Ltd. Company Summary
7.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
7.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Major Product Offerings
7.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue in Global Market (2018-2023)
7.9.5 Lucence Diagnostics Pte. Ltd. Key News & Latest Developments
7.10 GRAIL, Inc.
7.10.1 GRAIL, Inc. Company Summary
7.10.2 GRAIL, Inc. Business Overview
7.10.3 GRAIL, Inc. Cancer Biopsy Major Product Offerings
7.10.4 GRAIL, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.10.5 GRAIL, Inc. Key News & Latest Developments
7.11 Guardant Health
7.11.1 Guardant Health Company Summary
7.11.2 Guardant Health Business Overview
7.11.3 Guardant Health Cancer Biopsy Major Product Offerings
7.11.4 Guardant Health Cancer Biopsy Revenue in Global Market (2018-2023)
7.11.5 Guardant Health Key News & Latest Developments
7.12 Exact Sciences Corporation
7.12.1 Exact Sciences Corporation Company Summary
7.12.2 Exact Sciences Corporation Business Overview
7.12.3 Exact Sciences Corporation Cancer Biopsy Major Product Offerings
7.12.4 Exact Sciences Corporation Cancer Biopsy Revenue in Global Market (2018-2023)
7.12.5 Exact Sciences Corporation Key News & Latest Developments
7.13 Freenome Holdings, Inc.
7.13.1 Freenome Holdings, Inc. Company Summary
7.13.2 Freenome Holdings, Inc. Business Overview
7.13.3 Freenome Holdings, Inc. Cancer Biopsy Major Product Offerings
7.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.13.5 Freenome Holdings, Inc. Key News & Latest Developments
7.14 Oncimmune
7.14.1 Oncimmune Company Summary
7.14.2 Oncimmune Business Overview
7.14.3 Oncimmune Cancer Biopsy Major Product Offerings
7.14.4 Oncimmune Cancer Biopsy Revenue in Global Market (2018-2023)
7.14.5 Oncimmune Key News & Latest Developments
7.15 Chronix Biomedical, Inc.
7.15.1 Chronix Biomedical, Inc. Company Summary
7.15.2 Chronix Biomedical, Inc. Business Overview
7.15.3 Chronix Biomedical, Inc. Cancer Biopsy Major Product Offerings
7.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.15.5 Chronix Biomedical, Inc. Key News & Latest Developments
7.16 Personal Genome Diagnostics Inc.
7.16.1 Personal Genome Diagnostics Inc. Company Summary
7.16.2 Personal Genome Diagnostics Inc. Business Overview
7.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Major Product Offerings
7.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.16.5 Personal Genome Diagnostics Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Biopsy Market Opportunities & Trends in Global Market
Table 2. Cancer Biopsy Market Drivers in Global Market
Table 3. Cancer Biopsy Market Restraints in Global Market
Table 4. Key Players of Cancer Biopsy in Global Market
Table 5. Top Cancer Biopsy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Biopsy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Biopsy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Biopsy Product Type
Table 9. List of Global Tier 1 Cancer Biopsy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biopsy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Biopsy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Biopsy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Biopsy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Biopsy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Biopsy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Biopsy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Biopsy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Biopsy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Biopsy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Biopsy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Biopsy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Biopsy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Biopsy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Biopsy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Biopsy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Biopsy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Biopsy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Biopsy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Biopsy Revenue, (US$, Mn), 2024-2029
Table 30. Qiagen N.V. Company Summary
Table 31. Qiagen N.V. Cancer Biopsy Product Offerings
Table 32. Qiagen N.V. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 33. Qiagen N.V. Key News & Latest Developments
Table 34. Illumina, Inc. Company Summary
Table 35. Illumina, Inc. Cancer Biopsy Product Offerings
Table 36. Illumina, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 37. Illumina, Inc. Key News & Latest Developments
Table 38. ANGLE Plc Company Summary
Table 39. ANGLE Plc Cancer Biopsy Product Offerings
Table 40. ANGLE Plc Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 41. ANGLE Plc Key News & Latest Developments
Table 42. Myriad Genetics Company Summary
Table 43. Myriad Genetics Cancer Biopsy Product Offerings
Table 44. Myriad Genetics Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 45. Myriad Genetics Key News & Latest Developments
Table 46. Hologic, Inc. Company Summary
Table 47. Hologic, Inc. Cancer Biopsy Product Offerings
Table 48. Hologic, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 49. Hologic, Inc. Key News & Latest Developments
Table 50. Biocept, Inc. Company Summary
Table 51. Biocept, Inc. Cancer Biopsy Product Offerings
Table 52. Biocept, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 53. Biocept, Inc. Key News & Latest Developments
Table 54. Thermo Fisher Scientific, Inc. Company Summary
Table 55. Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offerings
Table 56. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 57. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 58. Danaher Company Summary
Table 59. Danaher Cancer Biopsy Product Offerings
Table 60. Danaher Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 61. Danaher Key News & Latest Developments
Table 62. Lucence Diagnostics Pte. Ltd. Company Summary
Table 63. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offerings
Table 64. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 65. Lucence Diagnostics Pte. Ltd. Key News & Latest Developments
Table 66. GRAIL, Inc. Company Summary
Table 67. GRAIL, Inc. Cancer Biopsy Product Offerings
Table 68. GRAIL, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 69. GRAIL, Inc. Key News & Latest Developments
Table 70. Guardant Health Company Summary
Table 71. Guardant Health Cancer Biopsy Product Offerings
Table 72. Guardant Health Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 73. Guardant Health Key News & Latest Developments
Table 74. Exact Sciences Corporation Company Summary
Table 75. Exact Sciences Corporation Cancer Biopsy Product Offerings
Table 76. Exact Sciences Corporation Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 77. Exact Sciences Corporation Key News & Latest Developments
Table 78. Freenome Holdings, Inc. Company Summary
Table 79. Freenome Holdings, Inc. Cancer Biopsy Product Offerings
Table 80. Freenome Holdings, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 81. Freenome Holdings, Inc. Key News & Latest Developments
Table 82. Oncimmune Company Summary
Table 83. Oncimmune Cancer Biopsy Product Offerings
Table 84. Oncimmune Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 85. Oncimmune Key News & Latest Developments
Table 86. Chronix Biomedical, Inc. Company Summary
Table 87. Chronix Biomedical, Inc. Cancer Biopsy Product Offerings
Table 88. Chronix Biomedical, Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 89. Chronix Biomedical, Inc. Key News & Latest Developments
Table 90. Personal Genome Diagnostics Inc. Company Summary
Table 91. Personal Genome Diagnostics Inc. Cancer Biopsy Product Offerings
Table 92. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue (US$, Mn) & (2018-2023)
Table 93. Personal Genome Diagnostics Inc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Biopsy Segment by Type in 2022
Figure 2. Cancer Biopsy Segment by Application in 2022
Figure 3. Global Cancer Biopsy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Biopsy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Biopsy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biopsy Revenue in 2022
Figure 8. By Type - Global Cancer Biopsy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Biopsy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Biopsy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Biopsy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Biopsy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Biopsy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Biopsy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Biopsy Revenue Market Share, 2018-2029
Figure 16. US Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Biopsy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Biopsy Revenue Market Share, 2018-2029
Figure 28. China Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Biopsy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Biopsy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Biopsy Revenue, (US$, Mn), 2018-2029
Figure 41. Qiagen N.V. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Illumina, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ANGLE Plc Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Myriad Genetics Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hologic, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biocept, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Danaher Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GRAIL, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Guardant Health Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Exact Sciences Corporation Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Freenome Holdings, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Oncimmune Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Chronix Biomedical, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
